Explore the uncertain future of Walgreens Boots Alliance (WBA) amid buyout hurdles, litigation risks & industry challenges.

Walgreens Boots (NASDAQ:WBA) fell 4.7% after a report that a Sycamore Partners deal for the drugstore chain is unlikely to ...

Shares of Walgreens Boots Alliance (NASDAQ: WBA) rose on Thursday, up as much as 7.3% before settling into a 2.2% gain by ...

Deutsche Bank downgraded Walgreens Boots Alliance (WBA) to Sell from Hold with a price target of $9, down from $11. The firm says the reports ...

Walgreens shares fell more than 5% Friday as details about a potential sale emerged and one analyst team said the stock had ...

Wall Street's main indexes were mixed in choppy trading on Friday as investors avoided large bets after data showed consumer ...

The deal hype started in early-December, when the Wall Street Journal reported Walgreens was in talks to sell itself to Sycamore Partners. Read: Walgreens' stock could see its best day ever. Is a ...

But not enough patients visited VillageMD’s doctors, and the business is now up for sale. Brewer exited in September 2023 and Walgreens last year took a $5.8bn after-tax charge related to VillageMD, ...

Happy Friday, everyone. So far this week, the S&P 500 is down 2.5% heading into the final trading day. The big Trump push is ...

The deal is not yet finalized. Other news includes: tariffs on the pharmaceutical industry and what it means for medicine; Pfizer putting emphasis on merit in the face of DEI overhaul; and more.

What the telehealth prescribers can’t do, the compounders are. A major drug compounder association, the Outsourcing Facilities Association, along with member North American Custom Laboratories, LLC, ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...